Progression of radiographic damage in patients with ankylosing spondylitis: Defining the central role of syndesmophytes

Annals of the Rheumatic Diseases

Volumn 66, Issue 7, 2007, Pages 910-915

  Baraliakos, X ^b   Listing, J ^c   Rudwaleit, M ^d   Haibel, H ^d   Brandt, J ^b   Sieper, J ^d   Braun, J ^a,b  

^a RHEUMAZENTRUM RUHRGEBIET   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c German Rheumatism Research Center   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB;

ADULT; ANKYLOSING SPONDYLITIS; ANKYLOSIS; ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MODIFIED STOKES ANKYLOSING SPONDYLITIS SPINAL SCORE; OSSIFICATION; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; SCORING SYSTEM; SPONDYLOPHYTE; SYNDESMOPHYTE;

ADULT; AGE FACTORS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LIGAMENTS, ARTICULAR; MALE; REPRODUCIBILITY OF RESULTS; SPINE; SPONDYLITIS, ANKYLOSING; TIME FACTORS;

EID: 34247145268     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.066415     Document Type: Article

References (30)

1. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
2. Braun J, Sieper J. The sacroiliac joint in the spondyloarthropathies. Curr Opin Rheumatol 1996;8:275-87.
3. Braun J, van der Heijde D. Imaging and scoring in ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002;16:573-604.
4. Heuft-Dorenbosch L, Landewé R, Weijers R, Wanders A, Houben H, van der Linden S, et al. Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroileitis in patients with recent onset inflammatory back pain. Ann Rheum Dis 2006;65:804-8.
5. Braun JBM, Sieper J. Radiology and pathology of the spondyloarthropathies. Rheum Dis Clin North Am 1998;24:697-735.
6. Spoorenberg A, de Vlam K, van der Linden S, Dougados M, Mielants H, van de Tempel H, et al. Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. J Rheumatol 2004;31:125-32.
7. Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005;64:179-82.
8. van der Heijde D, Simon L, Smolen J, Strand V, Sharp J, Boers M, et al. How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum 2002;47:215-18.
9. Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Saudan A, et al. Smallest detectable difference in radiological progression. J Rheumatol 1999;26:731-9.
10. Ravaud P, Giraudeau B, Auleley GR, Edouard-Noel R, Dougados M, Chastang C. Assessing smallest detectable change over time in continuous structural outcome measures: application to radiological change in knee osteoarthritis. J Clin Epidemiol 1999;52:1225-30.
11. Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 2005;64:1462-6.
12. van der Heijde D, Wanders A, Mielants H, Dougados M, Landewé R. Prediction of progression of radiographic damage over 4 years in patients with ankylosing spondylitis [abstract]. Ann Rheum Dis 2004;63(Suppl 1):98.
13. Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
14. Wanders AJ, Landewe RB, Spoorenberg A, Dougados M, van der Linden S, Mielants H, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004;50:2622-32.
15. Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J, et al. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 2004;63:1046-55.
16. Braun J, Baraliakos X, Brandt J, Sieper J. Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand J Rheumatol 2005;34:178-90.
17. Braun J, Baraliakos X, Godolias G, Bohm H. Therapy of ankylosing spondylitis-a review. Part I: conventional medical treatment and surgical therapy. Scand J Rheumatol 2005;34:97-108.
18. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
19. Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, et al. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis 2005;64:229-34.
20. Baraliakos X, Brandt J, Listing J, Haibel H, Sorensen H, Rudwaleit M, et al. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum 2005;53:856-63.
21. Braun J, Sieper J. Inception cohorts for spondyloarthropathies. Z Rheumatol 2000;59:117-21.
22. Rudwaleit M, Baraliakos X, Listing J, Sieper J, Braun J. The course of radiographic spinal lesions in patients with early ankylosing spondylitis over a 2-year follow up period [abstract]. Annual Meeting of the European League Against Rheumatism (EULAR), Vienna, Austria, 2005.
23. Landewé R, van der Heijde D. Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 2004;50:699-706.
24. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
25. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
26. Rau R, Wassenberg S, Herborn G, Perschel WT, Freitag G. Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol 2001;28:2608-15.
27. Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004;50:1051-65.
28. Finckh A, Simard JF, Duryea J, Liang MH, Huang J, Daneel S, et al. The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study. Arthritis Rheum 2006;54:54-9.
29. Kavanaugh A, Antoni CE, Gladman DD, Wassenberg S, Zhou B, Beutler A, et al. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Ann Rheum Dis 2006;65:1038-43.
30. Baraliakos X, Listing J, Brandt J, Rudwaleit M, Sieper J, Braun J. Radiographic progression in patients with ankylosing spondylitis after 2 years of continuous anti-TNFa therapy [abstract]. Ann Rheum Dis 2005;64(Suppl III):1462-6.